AAAAAA

   
Results: 1-14 |
Results: 14
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide
Authors: Lee-MacAry, AE Ross, EL Davies, D Laylor, R Honeychurch, J Glennie, MJ Snary, D Wilkinson, RW
Citation: Ae. Lee-macary et al., Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide, J IMMUNOL M, 252(1-2), 2001, pp. 83-92
Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies
Authors: Stockmeyer, B Elsasser, D Dechant, M Repp, R Gramatzki, M Glennie, MJ van de Winkel, JGJ Valerius, T
Citation: B. Stockmeyer et al., Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies, J IMMUNOL M, 248(1-2), 2001, pp. 103-111
CD40 ligation for immunotherapy of solid tumours
Authors: Todryk, SM Tutt, AL Green, MHA Smallwood, JA Halanek, N Dalgleish, AG Glennie, MJ
Citation: Sm. Todryk et al., CD40 ligation for immunotherapy of solid tumours, J IMMUNOL M, 248(1-2), 2001, pp. 139-147
Analysis of the oligomeric requirement for signaling by CD40 using solublemultimeric forms of its ligand, CD154
Authors: Haswell, LE Glennie, MJ Al-Shamkhani, A
Citation: Le. Haswell et al., Analysis of the oligomeric requirement for signaling by CD40 using solublemultimeric forms of its ligand, CD154, EUR J IMMUN, 31(10), 2001, pp. 3094-3100
Complement mediated cell death is associated with DNA fragmentation
Authors: Cragg, MS Howatt, WJ Bloodworth, L Anderson, VA Morgan, BP Glennie, MJ
Citation: Ms. Cragg et al., Complement mediated cell death is associated with DNA fragmentation, CELL DEAT D, 7(1), 2000, pp. 48-58
Signalling antibodies for the treatment of neoplastic disease
Authors: Glennie, MJ
Citation: Mj. Glennie, Signalling antibodies for the treatment of neoplastic disease, DIS MARKER, 16(1-2), 2000, pp. 63-63
Clinical trials of antibody therapy
Authors: Glennie, MJ Johnson, PWM
Citation: Mj. Glennie et Pwm. Johnson, Clinical trials of antibody therapy, IMMUNOL TOD, 21(8), 2000, pp. 403-410
Triggering FC alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy
Authors: Stockmeyer, B Dechant, M van Egmond, M Tutt, AL Sundarapandiyan, K Graziano, RF Repp, R Kalden, JR Gramatzki, M Glennie, MJ van de Winkel, JGJ Valerius, T
Citation: B. Stockmeyer et al., Triggering FC alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy, J IMMUNOL, 165(10), 2000, pp. 5954-5961
Therapeutic efficacy of Fc gamma RI/CD64-directed bispecific antibodies inB-cell lymphoma
Authors: Honeychurch, J Tutt, AL Valerius, T Heijnen, IAFM Van de Winkel, JGJ Glennie, MJ
Citation: J. Honeychurch et al., Therapeutic efficacy of Fc gamma RI/CD64-directed bispecific antibodies inB-cell lymphoma, BLOOD, 96(10), 2000, pp. 3544-3552
The application of monoclonal antibodies in the treatment of lymphoma
Authors: Glennie, MJ Honeychurch, J French, RR Tutt, AL
Citation: Mj. Glennie et al., The application of monoclonal antibodies in the treatment of lymphoma, METH MOL M, 40, 2000, pp. 85-97
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
Authors: French, RR Chan, HTC Tutt, AL Glennie, MJ
Citation: Rr. French et al., CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help, NAT MED, 5(5), 1999, pp. 548-553
Signaling antibodies in cancer therapy
Authors: Cragg, MS French, RR Glennie, MJ
Citation: Ms. Cragg et al., Signaling antibodies in cancer therapy, CURR OP IM, 11(5), 1999, pp. 541-547
Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells
Authors: Cragg, MS Zhang, L French, RR Glennie, MJ
Citation: Ms. Cragg et al., Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells, BR J CANC, 79(5-6), 1999, pp. 850-857
The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma
Authors: Illidge, TM Cragg, MS McBride, HM French, RR Glennie, MJ
Citation: Tm. Illidge et al., The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma, BLOOD, 94(1), 1999, pp. 233-243
Risultati: 1-14 |